nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—ALB—liver cancer	0.374	1	CbGaD
Norethindrone—CYP3A7—Sorafenib—liver cancer	0.0871	0.217	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0871	0.217	CbGbCtD
Norethindrone—CYP3A5—Sorafenib—liver cancer	0.0653	0.163	CbGbCtD
Norethindrone—CYP2C19—Sorafenib—liver cancer	0.0527	0.131	CbGbCtD
Norethindrone—ABCB1—Sorafenib—liver cancer	0.0425	0.106	CbGbCtD
Norethindrone—ABCB1—Doxorubicin—liver cancer	0.0258	0.0643	CbGbCtD
Norethindrone—CYP3A4—Sorafenib—liver cancer	0.0255	0.0635	CbGbCtD
Norethindrone—CYP3A4—Doxorubicin—liver cancer	0.0155	0.0385	CbGbCtD
Norethindrone—Embolism arterial—Epirubicin—liver cancer	0.0108	0.0856	CcSEcCtD
Norethindrone—Embolism arterial—Doxorubicin—liver cancer	0.01	0.0792	CcSEcCtD
Norethindrone—Carcinoma—Sorafenib—liver cancer	0.00699	0.0553	CcSEcCtD
Norethindrone—Cerebral haemorrhage—Sorafenib—liver cancer	0.00381	0.0301	CcSEcCtD
Norethindrone—Gastrointestinal symptom NOS—Sorafenib—liver cancer	0.00359	0.0284	CcSEcCtD
Norethindrone—Embolism—Sorafenib—liver cancer	0.00329	0.026	CcSEcCtD
Norethindrone—Neoplasm malignant—Sorafenib—liver cancer	0.00247	0.0195	CcSEcCtD
Norethindrone—Erythema nodosum—Epirubicin—liver cancer	0.0018	0.0143	CcSEcCtD
Norethindrone—Erythema nodosum—Doxorubicin—liver cancer	0.00167	0.0132	CcSEcCtD
Norethindrone—Pain in extremity—Sorafenib—liver cancer	0.00153	0.0121	CcSEcCtD
Norethindrone—Mood swings—Sorafenib—liver cancer	0.00145	0.0115	CcSEcCtD
Norethindrone—Blindness—Epirubicin—liver cancer	0.00141	0.0111	CcSEcCtD
Norethindrone—Breast disorder—Sorafenib—liver cancer	0.00138	0.0109	CcSEcCtD
Norethindrone—Blindness—Doxorubicin—liver cancer	0.0013	0.0103	CcSEcCtD
Norethindrone—Optic neuritis—Epirubicin—liver cancer	0.00127	0.01	CcSEcCtD
Norethindrone—Embolism—Epirubicin—liver cancer	0.00121	0.00961	CcSEcCtD
Norethindrone—Optic neuritis—Doxorubicin—liver cancer	0.00117	0.00928	CcSEcCtD
Norethindrone—Acute coronary syndrome—Sorafenib—liver cancer	0.00116	0.0092	CcSEcCtD
Norethindrone—Renal failure—Sorafenib—liver cancer	0.00116	0.00918	CcSEcCtD
Norethindrone—Myocardial infarction—Sorafenib—liver cancer	0.00116	0.00915	CcSEcCtD
Norethindrone—Embolism—Doxorubicin—liver cancer	0.00112	0.00889	CcSEcCtD
Norethindrone—Hepatobiliary disease—Sorafenib—liver cancer	0.00112	0.00883	CcSEcCtD
Norethindrone—Thrombosis—Epirubicin—liver cancer	0.0011	0.00871	CcSEcCtD
Norethindrone—Quinestrol—ESR1—liver cancer	0.00108	0.129	CrCbGaD
Norethindrone—Haemoglobin—Sorafenib—liver cancer	0.00107	0.00842	CcSEcCtD
Norethindrone—Haemorrhage—Sorafenib—liver cancer	0.00106	0.00838	CcSEcCtD
Norethindrone—Dermatitis atopic—Epirubicin—liver cancer	0.00105	0.00833	CcSEcCtD
Norethindrone—Vaginal haemorrhage—Epirubicin—liver cancer	0.00105	0.00833	CcSEcCtD
Norethindrone—Connective tissue disorder—Sorafenib—liver cancer	0.00104	0.00823	CcSEcCtD
Norethindrone—Thrombosis—Doxorubicin—liver cancer	0.00102	0.00806	CcSEcCtD
Norethindrone—Erythema multiforme—Sorafenib—liver cancer	0.001	0.00792	CcSEcCtD
Norethindrone—Dermatitis atopic—Doxorubicin—liver cancer	0.000975	0.00771	CcSEcCtD
Norethindrone—Vaginal haemorrhage—Doxorubicin—liver cancer	0.000975	0.00771	CcSEcCtD
Norethindrone—Immune system disorder—Sorafenib—liver cancer	0.000957	0.00757	CcSEcCtD
Norethindrone—Alopecia—Sorafenib—liver cancer	0.000936	0.0074	CcSEcCtD
Norethindrone—Mental disorder—Sorafenib—liver cancer	0.000928	0.00734	CcSEcCtD
Norethindrone—Neoplasm malignant—Epirubicin—liver cancer	0.000913	0.00722	CcSEcCtD
Norethindrone—Breast pain—Epirubicin—liver cancer	0.000894	0.00707	CcSEcCtD
Norethindrone—Ethynodiol—ESR1—liver cancer	0.000893	0.106	CrCbGaD
Norethindrone—Amenorrhoea—Epirubicin—liver cancer	0.000888	0.00702	CcSEcCtD
Norethindrone—Jaundice cholestatic—Epirubicin—liver cancer	0.000888	0.00702	CcSEcCtD
Norethindrone—Neoplasm malignant—Doxorubicin—liver cancer	0.000845	0.00668	CcSEcCtD
Norethindrone—Allylestrenol—ESR1—liver cancer	0.000843	0.1	CrCbGaD
Norethindrone—Breast pain—Doxorubicin—liver cancer	0.000827	0.00654	CcSEcCtD
Norethindrone—Mestranol—ESR1—liver cancer	0.000822	0.0978	CrCbGaD
Norethindrone—Amenorrhoea—Doxorubicin—liver cancer	0.000821	0.00649	CcSEcCtD
Norethindrone—Jaundice cholestatic—Doxorubicin—liver cancer	0.000821	0.00649	CcSEcCtD
Norethindrone—Desogestrel—ESR1—liver cancer	0.000812	0.0966	CrCbGaD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00078	0.00617	CcSEcCtD
Norethindrone—Pulmonary embolism—Epirubicin—liver cancer	0.00078	0.00617	CcSEcCtD
Norethindrone—Norgestimate—ESR1—liver cancer	0.000759	0.0903	CrCbGaD
Norethindrone—Anaphylactic shock—Sorafenib—liver cancer	0.000753	0.00595	CcSEcCtD
Norethindrone—Skin disorder—Sorafenib—liver cancer	0.000731	0.00578	CcSEcCtD
Norethindrone—Pulmonary embolism—Doxorubicin—liver cancer	0.000722	0.00571	CcSEcCtD
Norethindrone—Dyspepsia—Sorafenib—liver cancer	0.000663	0.00524	CcSEcCtD
Norethindrone—Etonogestrel—ESR1—liver cancer	0.000657	0.0782	CrCbGaD
Norethindrone—Thrombophlebitis—Epirubicin—liver cancer	0.000654	0.00517	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Sorafenib—liver cancer	0.00065	0.00514	CcSEcCtD
Norethindrone—Fatigue—Sorafenib—liver cancer	0.000649	0.00513	CcSEcCtD
Norethindrone—Photosensitivity—Epirubicin—liver cancer	0.000645	0.0051	CcSEcCtD
Norethindrone—Gastrointestinal pain—Sorafenib—liver cancer	0.000616	0.00487	CcSEcCtD
Norethindrone—Thrombophlebitis—Doxorubicin—liver cancer	0.000605	0.00478	CcSEcCtD
Norethindrone—Urticaria—Sorafenib—liver cancer	0.000598	0.00473	CcSEcCtD
Norethindrone—Photosensitivity—Doxorubicin—liver cancer	0.000596	0.00472	CcSEcCtD
Norethindrone—Abdominal pain—Sorafenib—liver cancer	0.000595	0.00471	CcSEcCtD
Norethindrone—Renal impairment—Epirubicin—liver cancer	0.000595	0.0047	CcSEcCtD
Norethindrone—Purpura—Epirubicin—liver cancer	0.000587	0.00464	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Epirubicin—liver cancer	0.000585	0.00462	CcSEcCtD
Norethindrone—Pain in extremity—Epirubicin—liver cancer	0.000566	0.00448	CcSEcCtD
Norethindrone—Migraine—Epirubicin—liver cancer	0.000557	0.00441	CcSEcCtD
Norethindrone—Affect lability—Epirubicin—liver cancer	0.000557	0.00441	CcSEcCtD
Norethindrone—Hypersensitivity—Sorafenib—liver cancer	0.000555	0.00439	CcSEcCtD
Norethindrone—Renal impairment—Doxorubicin—liver cancer	0.00055	0.00435	CcSEcCtD
Norethindrone—Purpura—Doxorubicin—liver cancer	0.000543	0.0043	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000541	0.00428	CcSEcCtD
Norethindrone—Asthenia—Sorafenib—liver cancer	0.00054	0.00427	CcSEcCtD
Norethindrone—Mood swings—Epirubicin—liver cancer	0.000536	0.00424	CcSEcCtD
Norethindrone—Pruritus—Sorafenib—liver cancer	0.000533	0.00421	CcSEcCtD
Norethindrone—Pain in extremity—Doxorubicin—liver cancer	0.000524	0.00414	CcSEcCtD
Norethindrone—Migraine—Doxorubicin—liver cancer	0.000516	0.00408	CcSEcCtD
Norethindrone—Affect lability—Doxorubicin—liver cancer	0.000516	0.00408	CcSEcCtD
Norethindrone—Breast disorder—Epirubicin—liver cancer	0.000512	0.00404	CcSEcCtD
Norethindrone—Dizziness—Sorafenib—liver cancer	0.000498	0.00394	CcSEcCtD
Norethindrone—Mood swings—Doxorubicin—liver cancer	0.000496	0.00392	CcSEcCtD
Norethindrone—Abdominal distension—Epirubicin—liver cancer	0.000493	0.00389	CcSEcCtD
Norethindrone—Vomiting—Sorafenib—liver cancer	0.000479	0.00378	CcSEcCtD
Norethindrone—Rash—Sorafenib—liver cancer	0.000475	0.00375	CcSEcCtD
Norethindrone—Dermatitis—Sorafenib—liver cancer	0.000474	0.00375	CcSEcCtD
Norethindrone—Breast disorder—Doxorubicin—liver cancer	0.000473	0.00374	CcSEcCtD
Norethindrone—Headache—Sorafenib—liver cancer	0.000472	0.00373	CcSEcCtD
Norethindrone—Levonorgestrel—ESR1—liver cancer	0.000465	0.0553	CrCbGaD
Norethindrone—Abdominal distension—Doxorubicin—liver cancer	0.000456	0.0036	CcSEcCtD
Norethindrone—Nausea—Sorafenib—liver cancer	0.000447	0.00354	CcSEcCtD
Norethindrone—Photosensitivity reaction—Epirubicin—liver cancer	0.000447	0.00353	CcSEcCtD
Norethindrone—Weight increased—Epirubicin—liver cancer	0.000445	0.00352	CcSEcCtD
Norethindrone—Fluoxymesterone—ESR1—liver cancer	0.000443	0.0527	CrCbGaD
Norethindrone—Drowsiness—Epirubicin—liver cancer	0.000436	0.00345	CcSEcCtD
Norethindrone—Renal failure—Epirubicin—liver cancer	0.000429	0.00339	CcSEcCtD
Norethindrone—Danazol—ESR1—liver cancer	0.000423	0.0504	CrCbGaD
Norethindrone—Photosensitivity reaction—Doxorubicin—liver cancer	0.000413	0.00327	CcSEcCtD
Norethindrone—Hepatobiliary disease—Epirubicin—liver cancer	0.000413	0.00326	CcSEcCtD
Norethindrone—Weight increased—Doxorubicin—liver cancer	0.000412	0.00326	CcSEcCtD
Norethindrone—Drowsiness—Doxorubicin—liver cancer	0.000404	0.00319	CcSEcCtD
Norethindrone—Renal failure—Doxorubicin—liver cancer	0.000397	0.00314	CcSEcCtD
Norethindrone—Haemoglobin—Epirubicin—liver cancer	0.000394	0.00311	CcSEcCtD
Norethindrone—Ethinyl Estradiol—ESR1—liver cancer	0.000392	0.0466	CrCbGaD
Norethindrone—Haemorrhage—Epirubicin—liver cancer	0.000392	0.0031	CcSEcCtD
Norethindrone—Hepatitis—Epirubicin—liver cancer	0.000392	0.0031	CcSEcCtD
Norethindrone—Connective tissue disorder—Epirubicin—liver cancer	0.000385	0.00304	CcSEcCtD
Norethindrone—Hepatobiliary disease—Doxorubicin—liver cancer	0.000382	0.00302	CcSEcCtD
Norethindrone—Erythema multiforme—Epirubicin—liver cancer	0.00037	0.00293	CcSEcCtD
Norethindrone—Haemoglobin—Doxorubicin—liver cancer	0.000364	0.00288	CcSEcCtD
Norethindrone—Hepatitis—Doxorubicin—liver cancer	0.000362	0.00287	CcSEcCtD
Norethindrone—Haemorrhage—Doxorubicin—liver cancer	0.000362	0.00287	CcSEcCtD
Norethindrone—Connective tissue disorder—Doxorubicin—liver cancer	0.000356	0.00282	CcSEcCtD
Norethindrone—Immune system disorder—Epirubicin—liver cancer	0.000354	0.0028	CcSEcCtD
Norethindrone—Alopecia—Epirubicin—liver cancer	0.000346	0.00274	CcSEcCtD
Norethindrone—Mental disorder—Epirubicin—liver cancer	0.000343	0.00271	CcSEcCtD
Norethindrone—Erythema multiforme—Doxorubicin—liver cancer	0.000343	0.00271	CcSEcCtD
Norethindrone—Flatulence—Epirubicin—liver cancer	0.000336	0.00266	CcSEcCtD
Norethindrone—Tension—Epirubicin—liver cancer	0.000335	0.00265	CcSEcCtD
Norethindrone—Nervousness—Epirubicin—liver cancer	0.000331	0.00262	CcSEcCtD
Norethindrone—Immune system disorder—Doxorubicin—liver cancer	0.000327	0.00259	CcSEcCtD
Norethindrone—Alopecia—Doxorubicin—liver cancer	0.00032	0.00253	CcSEcCtD
Norethindrone—Mental disorder—Doxorubicin—liver cancer	0.000317	0.00251	CcSEcCtD
Norethindrone—Flatulence—Doxorubicin—liver cancer	0.000311	0.00246	CcSEcCtD
Norethindrone—Tension—Doxorubicin—liver cancer	0.00031	0.00245	CcSEcCtD
Norethindrone—Nervousness—Doxorubicin—liver cancer	0.000306	0.00242	CcSEcCtD
Norethindrone—Convulsion—Epirubicin—liver cancer	0.000295	0.00234	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000288	0.00228	CcSEcCtD
Norethindrone—Anaphylactic shock—Epirubicin—liver cancer	0.000278	0.0022	CcSEcCtD
Norethindrone—Oedema—Epirubicin—liver cancer	0.000278	0.0022	CcSEcCtD
Norethindrone—Convulsion—Doxorubicin—liver cancer	0.000273	0.00216	CcSEcCtD
Norethindrone—Skin disorder—Epirubicin—liver cancer	0.00027	0.00214	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000267	0.00211	CcSEcCtD
Norethindrone—Anaphylactic shock—Doxorubicin—liver cancer	0.000257	0.00204	CcSEcCtD
Norethindrone—Oedema—Doxorubicin—liver cancer	0.000257	0.00204	CcSEcCtD
Norethindrone—Insomnia—Epirubicin—liver cancer	0.000252	0.00199	CcSEcCtD
Norethindrone—Skin disorder—Doxorubicin—liver cancer	0.00025	0.00198	CcSEcCtD
Norethindrone—Somnolence—Epirubicin—liver cancer	0.000247	0.00196	CcSEcCtD
Norethindrone—Dyspepsia—Epirubicin—liver cancer	0.000245	0.00194	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Epirubicin—liver cancer	0.00024	0.0019	CcSEcCtD
Norethindrone—Fatigue—Epirubicin—liver cancer	0.00024	0.0019	CcSEcCtD
Norethindrone—Insomnia—Doxorubicin—liver cancer	0.000233	0.00184	CcSEcCtD
Norethindrone—Somnolence—Doxorubicin—liver cancer	0.000229	0.00181	CcSEcCtD
Norethindrone—Gastrointestinal pain—Epirubicin—liver cancer	0.000228	0.0018	CcSEcCtD
Norethindrone—Dyspepsia—Doxorubicin—liver cancer	0.000227	0.00179	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000222	0.00176	CcSEcCtD
Norethindrone—Fatigue—Doxorubicin—liver cancer	0.000222	0.00176	CcSEcCtD
Norethindrone—Urticaria—Epirubicin—liver cancer	0.000221	0.00175	CcSEcCtD
Norethindrone—Abdominal pain—Epirubicin—liver cancer	0.00022	0.00174	CcSEcCtD
Norethindrone—Progesterone—ESR1—liver cancer	0.000219	0.0261	CrCbGaD
Norethindrone—Gastrointestinal pain—Doxorubicin—liver cancer	0.000211	0.00166	CcSEcCtD
Norethindrone—Hypersensitivity—Epirubicin—liver cancer	0.000205	0.00162	CcSEcCtD
Norethindrone—Urticaria—Doxorubicin—liver cancer	0.000205	0.00162	CcSEcCtD
Norethindrone—Abdominal pain—Doxorubicin—liver cancer	0.000204	0.00161	CcSEcCtD
Norethindrone—Asthenia—Epirubicin—liver cancer	0.0002	0.00158	CcSEcCtD
Norethindrone—Pruritus—Epirubicin—liver cancer	0.000197	0.00156	CcSEcCtD
Norethindrone—Hypersensitivity—Doxorubicin—liver cancer	0.00019	0.0015	CcSEcCtD
Norethindrone—Asthenia—Doxorubicin—liver cancer	0.000185	0.00146	CcSEcCtD
Norethindrone—Dizziness—Epirubicin—liver cancer	0.000184	0.00145	CcSEcCtD
Norethindrone—Pruritus—Doxorubicin—liver cancer	0.000182	0.00144	CcSEcCtD
Norethindrone—Vomiting—Epirubicin—liver cancer	0.000177	0.0014	CcSEcCtD
Norethindrone—Progesterone—CYP1A1—liver cancer	0.000175	0.0209	CrCbGaD
Norethindrone—Rash—Epirubicin—liver cancer	0.000175	0.00139	CcSEcCtD
Norethindrone—Dermatitis—Epirubicin—liver cancer	0.000175	0.00139	CcSEcCtD
Norethindrone—Headache—Epirubicin—liver cancer	0.000174	0.00138	CcSEcCtD
Norethindrone—Dizziness—Doxorubicin—liver cancer	0.00017	0.00135	CcSEcCtD
Norethindrone—Testosterone—CYP1A1—liver cancer	0.000166	0.0197	CrCbGaD
Norethindrone—Nausea—Epirubicin—liver cancer	0.000165	0.00131	CcSEcCtD
Norethindrone—Vomiting—Doxorubicin—liver cancer	0.000164	0.00129	CcSEcCtD
Norethindrone—Rash—Doxorubicin—liver cancer	0.000162	0.00128	CcSEcCtD
Norethindrone—Dermatitis—Doxorubicin—liver cancer	0.000162	0.00128	CcSEcCtD
Norethindrone—Headache—Doxorubicin—liver cancer	0.000161	0.00128	CcSEcCtD
Norethindrone—Methyltestosterone—ALB—liver cancer	0.000159	0.0189	CrCbGaD
Norethindrone—Nausea—Doxorubicin—liver cancer	0.000153	0.00121	CcSEcCtD
Norethindrone—Testosterone—ALB—liver cancer	9.24e-05	0.011	CrCbGaD
Norethindrone—CYP3A7—Metabolism—PSMD10—liver cancer	2.92e-05	0.000323	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	2.91e-05	0.000322	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—H2AFX—liver cancer	2.9e-05	0.000321	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	2.89e-05	0.00032	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	2.85e-05	0.000316	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CPT1B—liver cancer	2.84e-05	0.000315	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GLUL—liver cancer	2.84e-05	0.000315	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GOT2—liver cancer	2.84e-05	0.000315	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ALDOB—liver cancer	2.84e-05	0.000314	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—UGDH—liver cancer	2.82e-05	0.000312	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GLUL—liver cancer	2.77e-05	0.000307	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CPT1B—liver cancer	2.77e-05	0.000307	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTA4—liver cancer	2.74e-05	0.000304	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NR1H4—liver cancer	2.74e-05	0.000303	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CRABP1—liver cancer	2.71e-05	0.0003	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTA3—liver cancer	2.69e-05	0.000298	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.68e-05	0.000297	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	2.68e-05	0.000296	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTA2—liver cancer	2.67e-05	0.000296	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NR1H4—liver cancer	2.67e-05	0.000296	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CYP2E1—liver cancer	2.67e-05	0.000296	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—EPT1—liver cancer	2.65e-05	0.000294	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	2.64e-05	0.000292	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTA3—liver cancer	2.63e-05	0.000291	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TERT—liver cancer	2.62e-05	0.00029	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTA1—liver cancer	2.58e-05	0.000286	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NAT2—liver cancer	2.55e-05	0.000282	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	2.53e-05	0.00028	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—TAT—liver cancer	2.51e-05	0.000278	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CYCS—liver cancer	2.5e-05	0.000277	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—MAPK14—liver cancer	2.49e-05	0.000276	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTA4—liver cancer	2.46e-05	0.000273	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	2.46e-05	0.000272	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.45e-05	0.000272	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GOT1—liver cancer	2.45e-05	0.000272	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GGT1—liver cancer	2.45e-05	0.000272	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ALDOB—liver cancer	2.44e-05	0.000271	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	2.42e-05	0.000269	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	2.42e-05	0.000268	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—F2—liver cancer	2.41e-05	0.000267	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.41e-05	0.000267	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTA4—liver cancer	2.4e-05	0.000266	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTA2—liver cancer	2.4e-05	0.000266	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—KDR—liver cancer	2.4e-05	0.000265	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAPK14—liver cancer	2.38e-05	0.000264	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—HPGDS—liver cancer	2.37e-05	0.000262	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTA2—liver cancer	2.34e-05	0.000259	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—ESR1—liver cancer	2.33e-05	0.000259	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CRABP1—liver cancer	2.33e-05	0.000258	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	2.33e-05	0.000258	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTA1—liver cancer	2.32e-05	0.000256	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PIK3CG—liver cancer	2.31e-05	0.000256	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—F2—liver cancer	2.31e-05	0.000255	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NAT2—liver cancer	2.29e-05	0.000254	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTA1—liver cancer	2.26e-05	0.00025	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	2.26e-05	0.00025	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	2.24e-05	0.000248	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NAT2—liver cancer	2.23e-05	0.000248	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—APC—liver cancer	2.21e-05	0.000244	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PIK3CG—liver cancer	2.21e-05	0.000244	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GSTP1—liver cancer	2.2e-05	0.000244	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.2e-05	0.000244	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALDOB—liver cancer	2.19e-05	0.000243	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—HMOX1—liver cancer	2.17e-05	0.000241	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALDOB—liver cancer	2.14e-05	0.000237	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PSMA4—liver cancer	2.11e-05	0.000234	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PSMD10—liver cancer	2.11e-05	0.000234	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.1e-05	0.000233	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CRABP1—liver cancer	2.09e-05	0.000232	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	2.09e-05	0.000232	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—BRAF—liver cancer	2.07e-05	0.00023	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.06e-05	0.000228	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GOT2—liver cancer	2.05e-05	0.000227	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CRABP1—liver cancer	2.04e-05	0.000226	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.04e-05	0.000226	CbGpPWpGaD
Norethindrone—ALB—Metabolism—HPGDS—liver cancer	2.04e-05	0.000226	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PIK3CD—liver cancer	2.03e-05	0.000225	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.03e-05	0.000225	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GSTM1—liver cancer	2.02e-05	0.000224	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—SERPINE1—liver cancer	2.01e-05	0.000222	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.99e-05	0.000221	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PIK3CD—liver cancer	1.94e-05	0.000215	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP2E1—liver cancer	1.93e-05	0.000214	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—SERPINE1—liver cancer	1.92e-05	0.000213	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CYP1A1—liver cancer	1.92e-05	0.000212	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.89e-05	0.000209	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—MYC—liver cancer	1.87e-05	0.000207	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.85e-05	0.000205	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HPGDS—liver cancer	1.83e-05	0.000203	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.82e-05	0.000202	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PSMA4—liver cancer	1.82e-05	0.000201	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PSMD10—liver cancer	1.82e-05	0.000201	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—RAF1—liver cancer	1.81e-05	0.000201	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYCS—liver cancer	1.81e-05	0.0002	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—MTHFR—liver cancer	1.79e-05	0.000198	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HPGDS—liver cancer	1.79e-05	0.000198	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GGT1—liver cancer	1.77e-05	0.000196	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GOT1—liver cancer	1.77e-05	0.000196	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GOT2—liver cancer	1.77e-05	0.000196	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PIK3CB—liver cancer	1.77e-05	0.000196	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PPARA—liver cancer	1.75e-05	0.000194	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—RAF1—liver cancer	1.73e-05	0.000192	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CPT1B—liver cancer	1.71e-05	0.000189	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GLUL—liver cancer	1.71e-05	0.000189	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	1.71e-05	0.000189	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PIK3CB—liver cancer	1.69e-05	0.000187	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MTOR—liver cancer	1.69e-05	0.000187	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.68e-05	0.000186	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP2E1—liver cancer	1.66e-05	0.000184	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.66e-05	0.000184	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NR1H4—liver cancer	1.65e-05	0.000182	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.64e-05	0.000181	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PSMA4—liver cancer	1.63e-05	0.000181	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PSMD10—liver cancer	1.63e-05	0.000181	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IL2—liver cancer	1.62e-05	0.00018	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTA3—liver cancer	1.62e-05	0.000179	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.61e-05	0.000178	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PSMA4—liver cancer	1.59e-05	0.000176	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PSMD10—liver cancer	1.59e-05	0.000176	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTP1—liver cancer	1.59e-05	0.000176	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GOT2—liver cancer	1.59e-05	0.000176	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CDKN1B—liver cancer	1.59e-05	0.000176	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—HMOX1—liver cancer	1.57e-05	0.000174	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	1.57e-05	0.000174	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CASP3—liver cancer	1.56e-05	0.000172	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYCS—liver cancer	1.55e-05	0.000172	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL2—liver cancer	1.55e-05	0.000172	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GOT2—liver cancer	1.55e-05	0.000172	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GOT1—liver cancer	1.53e-05	0.000169	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GGT1—liver cancer	1.53e-05	0.000169	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.52e-05	0.000168	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CCND1—liver cancer	1.51e-05	0.000168	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—JUN—liver cancer	1.51e-05	0.000167	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CG—liver cancer	1.5e-05	0.000166	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CTNNB1—liver cancer	1.5e-05	0.000166	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP2E1—liver cancer	1.49e-05	0.000165	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTA4—liver cancer	1.48e-05	0.000164	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MMP9—liver cancer	1.47e-05	0.000163	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CDKN1A—liver cancer	1.46e-05	0.000162	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTM1—liver cancer	1.46e-05	0.000162	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP2E1—liver cancer	1.46e-05	0.000161	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PPARG—liver cancer	1.45e-05	0.000161	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.44e-05	0.00016	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTA2—liver cancer	1.44e-05	0.00016	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAPK8—liver cancer	1.43e-05	0.000158	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYCS—liver cancer	1.4e-05	0.000155	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTA1—liver cancer	1.39e-05	0.000154	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYP1A1—liver cancer	1.39e-05	0.000154	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—VEGFA—liver cancer	1.38e-05	0.000153	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NAT2—liver cancer	1.38e-05	0.000152	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.37e-05	0.000152	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTP1—liver cancer	1.37e-05	0.000152	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GOT1—liver cancer	1.37e-05	0.000152	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GGT1—liver cancer	1.37e-05	0.000152	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYCS—liver cancer	1.36e-05	0.000151	CbGpPWpGaD
Norethindrone—ALB—Metabolism—HMOX1—liver cancer	1.35e-05	0.00015	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GGT1—liver cancer	1.34e-05	0.000148	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GOT1—liver cancer	1.34e-05	0.000148	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CD—liver cancer	1.32e-05	0.000146	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALDOB—liver cancer	1.32e-05	0.000146	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—VEGFA—liver cancer	1.32e-05	0.000146	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—STAT3—liver cancer	1.31e-05	0.000145	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ALB—liver cancer	1.3e-05	0.000144	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—AKT1—liver cancer	1.29e-05	0.000143	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—MTHFR—liver cancer	1.29e-05	0.000143	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPARA—liver cancer	1.27e-05	0.00014	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TGFB1—liver cancer	1.27e-05	0.00014	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTM1—liver cancer	1.26e-05	0.00014	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CRABP1—liver cancer	1.26e-05	0.000139	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTP1—liver cancer	1.23e-05	0.000136	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MYC—liver cancer	1.21e-05	0.000134	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HMOX1—liver cancer	1.21e-05	0.000134	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TGFB1—liver cancer	1.21e-05	0.000134	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTP1—liver cancer	1.2e-05	0.000133	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYP1A1—liver cancer	1.19e-05	0.000132	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HMOX1—liver cancer	1.18e-05	0.000131	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—KRAS—liver cancer	1.17e-05	0.00013	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CB—liver cancer	1.15e-05	0.000128	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTM1—liver cancer	1.13e-05	0.000125	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—KRAS—liver cancer	1.12e-05	0.000124	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MTHFR—liver cancer	1.11e-05	0.000123	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTM1—liver cancer	1.1e-05	0.000122	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HPGDS—liver cancer	1.1e-05	0.000122	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPARA—liver cancer	1.09e-05	0.000121	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CG—liver cancer	1.09e-05	0.00012	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PIK3CA—liver cancer	1.08e-05	0.000119	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYP1A1—liver cancer	1.07e-05	0.000119	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPARG—liver cancer	1.05e-05	0.000116	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYP1A1—liver cancer	1.05e-05	0.000116	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TP53—liver cancer	1.04e-05	0.000115	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PIK3CA—liver cancer	1.03e-05	0.000114	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MTHFR—liver cancer	9.99e-06	0.000111	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TP53—liver cancer	9.97e-06	0.00011	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—HRAS—liver cancer	9.97e-06	0.00011	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.81e-06	0.000109	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PSMA4—liver cancer	9.81e-06	0.000109	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PSMD10—liver cancer	9.81e-06	0.000109	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPARA—liver cancer	9.8e-06	0.000109	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MTHFR—liver cancer	9.75e-06	0.000108	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPARA—liver cancer	9.57e-06	0.000106	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CD—liver cancer	9.55e-06	0.000106	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GOT2—liver cancer	9.54e-06	0.000106	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—HRAS—liver cancer	9.54e-06	0.000106	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ALB—liver cancer	9.42e-06	0.000104	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CG—liver cancer	9.35e-06	0.000104	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6—liver cancer	9.13e-06	0.000101	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPARG—liver cancer	9.03e-06	0.0001	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP2E1—liver cancer	8.97e-06	9.94e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.81e-06	9.75e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—AKT1—liver cancer	8.8e-06	9.75e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—AKT1—liver cancer	8.42e-06	9.33e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CG—liver cancer	8.4e-06	9.3e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYCS—liver cancer	8.39e-06	9.3e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CB—liver cancer	8.32e-06	9.22e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GGT1—liver cancer	8.24e-06	9.12e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GOT1—liver cancer	8.24e-06	9.12e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CD—liver cancer	8.22e-06	9.11e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CG—liver cancer	8.19e-06	9.08e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPARG—liver cancer	8.1e-06	8.98e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPARG—liver cancer	7.91e-06	8.76e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTP1—liver cancer	7.4e-06	8.2e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CD—liver cancer	7.38e-06	8.18e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HMOX1—liver cancer	7.3e-06	8.08e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALB—liver cancer	7.29e-06	8.07e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CD—liver cancer	7.2e-06	7.98e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CB—liver cancer	7.17e-06	7.94e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALB—liver cancer	7.11e-06	7.88e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CA—liver cancer	7.02e-06	7.77e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTM1—liver cancer	6.8e-06	7.53e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYP1A1—liver cancer	6.45e-06	7.14e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CB—liver cancer	6.43e-06	7.13e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CB—liver cancer	6.28e-06	6.96e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MTHFR—liver cancer	6.01e-06	6.66e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARA—liver cancer	5.89e-06	6.53e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—AKT1—liver cancer	5.73e-06	6.35e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CA—liver cancer	5.07e-06	5.62e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CG—liver cancer	5.05e-06	5.59e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARG—liver cancer	4.87e-06	5.4e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CD—liver cancer	4.44e-06	4.92e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALB—liver cancer	4.38e-06	4.85e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CA—liver cancer	4.37e-06	4.84e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AKT1—liver cancer	4.14e-06	4.59e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CA—liver cancer	3.92e-06	4.34e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CB—liver cancer	3.87e-06	4.29e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CA—liver cancer	3.83e-06	4.24e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AKT1—liver cancer	3.57e-06	3.95e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AKT1—liver cancer	3.2e-06	3.55e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AKT1—liver cancer	3.13e-06	3.46e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CA—liver cancer	2.36e-06	2.61e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AKT1—liver cancer	1.93e-06	2.13e-05	CbGpPWpGaD
